Amylin Pharmaceuticals to Webcast Conference Call
October 31 2007 - 6:00AM
PR Newswire (US)
SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast a conference call
on Wednesday, October 31, 2007 at 8:30 a.m. ET/5:30 a.m. PT to
discuss today's release of the once-weekly exenatide long-acting
release study results. Daniel M. Bradbury, Amylin's President and
Chief Executive Officer, will lead the call. The call will be
webcast live through Amylin's corporate website and a recording
will be made available following the close of the call. To access
the webcast, please log on to http://www.amylin.com/ approximately
fifteen minutes prior to the call to register, download and install
any necessary audio software. For those without access to the
Internet, the live call may be accessed by phone by calling (866)
356-3095 (domestic) or (617) 597-5391 (international), passcode
19644079. A replay of the call will also be available by phone for
24 hours beginning approximately one hour after the close of the
call and can be accessed at (888) 286-8010 (domestic) or (617)
801-6888 (international), passcode 23209035. About Amylin
Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is headquartered in San Diego,
California with over 1,800 employees nationwide. Further
information on Amylin Pharmaceuticals is available at
http://www.amylin.com/. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Alice Bahner Izzo of Amylin Pharmaceuticals, Inc.,
Executive Director, Corporate Affairs, +1-858-552-2200, ext. 7272
Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024